Scripta Insights, an organization that develops pharmacy navigation options for self-insured employers, well being plans and members, is getting into right into a strategic partnership with RxSaveCard, which gives pharmacy profit cost-containment and fee choices.
The partnership goals to assist self-insured employers fulfill their fiduciary obligations and scale back prescription drug prices by offering members with entry to reasonably priced medicine choices, whether or not coated by their well being plan or through cash-pay options.
In an announcement, Scripta defined that it’ll combine RxSaveCard into its Rx Navigation platform, which the corporate says will profit purchasers who’ve the absolutely custom-made resolution in place.
For members, it goals to assist them save on high-cost specialty medicine, together with GLP-1s.
For self-insured employers, the objective is to scale back plan spend by avoiding conventional pharmacy profit supervisor (PBM) markups.
Moreover, Scripta will steer members to essentially the most cost-effective medicine choices accessible.
That might imply a coated drug via their well being plan, changing to a inexpensive different or utilizing a money pay supply like RxSaveCard.
Scripta said that the RxSaveCard additionally permits plan sponsors to supply low- or no-cost drugs to members with out requiring a change to a brand new PBM.
Moreover, employers fund a pay as you go digital card each month that covers all or a part of the focused drug prices.
Members will be capable to use the cardboard at over 65,000 pharmacies, together with Mark Cuban Cost Plus Drugs and Lilly Direct, with the employer-funded quantity utilized mechanically at checkout.
In response to Scripta, members can have the power to seek for RxSaveCard discounted costs and pharmacy options and entry their playing cards instantly within the Scripta member app. Scripta can even present purchasers with detailed reporting on their financial savings.
“RxSaveCard shares our dedication to innovating the normal pharmacy advantages mannequin and placing sufferers again in command of their prescription decisions,” Eric Levin, CEO of Scripta Insights, stated in an announcement.
“By integrating RxSaveCard’s nationwide low cost community into our Scripta Financial savings Mapper, we’re making it even simpler for members to check all their choices, together with new money pay options, and get monetary savings on their prescriptions.”
THE LARGER TREND
In Might, Scripta Insights launched its GLP-1 Navigator, a software within the Scripta member app that gives sufferers with details about GLP-1 drugs in a centralized information.
Up to date weekly, Scripta’s GLP-1 Navigator helps members perceive their choices and the trade-offs, no matter whether or not their plan covers GLP-1s.
In 2024, Scripta Insights introduced it raised $17 million in Sequence B funding, led by Aquiline, bringing its whole funding to $42 million on the time.
Contour Enterprise Companions, Eastside Companions, and ReMY Buyers participated within the spherical.
In 2023, Scripta Insights collaborated with Mark Cuban Price Plus Drug Firm.
In an announcement, the corporate stated the connection furthered Scripta’s mission to get members The Proper Meds at The Finest Value.
In 2024, RxSaveCard raised $1.7 million in seed funding to drive development and broaden client entry to reasonably priced drugs.
In response to BusinessWire, the spherical was led by Distributed Ventures with participation from trade insiders.
